Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News NRX Pharmaceuticals Inc NRXP

Alternate Symbol(s):  NRXPW

Financial Services Healthcare Biotechnology
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NRXP)

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

GlobeNewswire 2 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions

GlobeNewswire 9 days ago

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

GlobeNewswire December 18, 2025

NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation

GlobeNewswire December 3, 2025

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE(TM), a Preservative-Free IV Ketamine

GlobeNewswire December 2, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

GlobeNewswire December 2, 2025

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets' Twenty First Annual Emerging Growth Equity Conference

GlobeNewswire December 1, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire November 17, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025

GlobeNewswire November 12, 2025
View More News ››

Opinion & Analysis (NDAQ:NRXP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NRXP)

RE:RE:RE:New front runner for FDA Ketamine Approval !!!

Latest News release from PharmaTher (PHRM) and OTCNASDAQ (PHRRF)....Enjoy the read... Pharmather receives FDA approval goal date for...
Guytorule - July 4, 2025

RE:RE:New front runner for FDA Ketamine Approval !!!

Further...PharmaTher (THRM) will be disrupting the entire suppy chain for Ketamine once they get FDA approval very shortly by August 9th...
Guytorule - July 4, 2025

RE:New front runner for FDA Ketamine Approval !!!

Also listed IN U.S  on  "OTCNASDAQ"  under PHRRF....
Guytorule - July 4, 2025

New front runner for FDA Ketamine Approval !!!

Front runner and soon to become key leader to bring Ketamine to market world wide is PHARMATHER (PHRM) listed on Canadian exchange. They...
Guytorule - July 4, 2025

RE:DD for NRXP

Have you looked at PHRM?  It's along the same lines as this stock.  And it's much cheaper..
Sailormark - July 1, 2025

$NRXP $3.65 +28.07% on Today's news! NRx Pharmaceuticals

$NRXP $3.65 +28.07% on Today's news!  NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Advances Relationship with Anson Funds with $8.9...
MasterJediJazz2 - January 28, 2025
View more Bullboard ››

SEGO Resources Inc.

SEGO Resources Inc.

Sego Resources Inc., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral ...
View More »

Podcasts